newsfilter
← Latest News
Business Wire·

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

Data presented at AACR and ASCO provide further validation of the potential of Bicycle® technology to deliver oncology therapeutics with improved benefit/risk profiles compared to existing modalities Expanded